Integrated Generic Platform offering Concept to Commercialization Solutions

Overview

At Cohance, our generic API platform offers an integrated solutions approach, uniquely positioned to serve our global customer base. With 30+ years of rich legacy, backed by deep chemistry capabilities, global regulatory expertise, and reliable supply network, we serve customers across 60+ countries, from 8 cGMP facilities, offering 50+ molecules across various therapeutic areas. We partner with leading pharma innovators and global generics, collaborating across the product lifecyle stage.

 
Generics API Landing Page

Why partner with us?

Generic APIs_LP_Why Coahance

Why partner with us?

  • Integrated Solutions Approach – Unified generic platform offering APIs, Pellets, and Finished Dosage Forms
  • Chemistry at Core – 3 dedicated R&D centres with 150+ R&D strength
  • Global Portfolio – 50+ molecules with customer base across 60+ countries
  • Flexible Offerings – From Catalog to customized solutions
  • Scale and Reliability – 8 cGMP sites offering kilo to multi-ton capacities
  • Regulatory Compliance – Global regulatory accreditations such as USFDA, EU-GMP, ANVISA, PMDA, NPMA, Health Canada, TGA, KFDA, and more

Our Integrated Capabilities

APIs

  • Partner of choice offering Scale, Compliance, and Reliability
  • Deep chemistry capabilities, scalable capacities, and robust regulatory track record
  • 1600+ KL operational capacity across 5 cGMP facilities with global accreditations – USFDA, EDQM, PMDA, NMPA, KFDA, ANVISA, and others
  • Diverse portfolio of 50+ molecules covering multiple therapeutic areas

Pellets

  • Pelletized intermediates for modified-release formulations
  • Strong backward integration with in-house APIs
  • BE-oriented design; strong regulatory expertise to support global filings
  • 830+ MT operational capacity across 2 cGMP facilities

FDFs

  • Vertically integrated CMO/CDMO solutions for generic pharma
  • Multi-dosage capabilities including Oral Solids, Oral Liquids, Topical Cloths, Semi-solid Topicals, and others
  • 3 cGMP facilities with global regulatory accreditations (USFDA, EU-GMP, Health Canada, TGA, etc.)
  • Expertise in in-house development, tech-transfer, dossier filing, and lifecycle support

Facilities

Genome valley

API R&D, Genome Valley
Hyderabad, India

API-R&D-II-Unit,-Ankaleshwar

API R&D, Ankaleshwar
Gujarat, India

Vijaywada API-Unit-I,-Jaggayapet,

API Unit-I, Jaggayapet
Vijayawada, India

API facility

API Unit-II, Achutapuram
Vizag, India

API-R&D-II-Unit,-Ankaleshwar

API Unit-III, Ankaleshwar
Gujarat, India

Pashamylaram facility

CDMO Unit-III, Pashamylaram
Hyderabad, India

Designed to seamlessly scale from clinical to commercial manufacturing, these facilities are compliant with global regulatory standards including the US FDA.

FDF-Unit-I,-Nacharam

FDF Unit-I, Nacharam
Hyderabad, India

FDF-Unit-II,-Jadcherla

FDF Unit-II, Jadcherla
Hyderabad, India

Designed to seamlessly scale from clinical to commercial manufacturing, these facilities are compliant with global regulatory standards including the US FDA.

FDF-Unit-I,-Nacharam

FDF Unit-I, Nacharam
Hyderabad, India

FDF-Unit-II,-Jadcherla

FDF Unit-II, Jadcherla
Hyderabad, India

FDF facility

FDF Unit-III, Pashamylaram
Hyderabad, India

FDF Unit Shamshabad

FDF Unit IV, Shamshabad
Hyderabad, India

FD-R&D,-Nacharam

FDF R&D, Nacharam
Hyderabad, India

Let’s Shape the Future of Generics - Together
From ideation to commercialization, Cohance’s Generic API platform offers unmatched reliability and integrated support.